Marco de Morpurgo > DLA Piper > Rome, Italy > Lawyer Profile

The ‘responsive and pragmatic‘ team at DLA Piper leverages the firm’s international network of offices to act for global pharma companies in a range of matters. Marco de Morpurgo divides his time between the Rome and Brussels offices, and is well versed in assisting with market access issues, advertising matters and product classification cases; he co-heads the practice with Joost Haans. Jean-Christophe Top joined the team in January 2024.

DLA Piper’s broad offering regularly handles cross-border joint ventures, private equity investment mandates, and clinical trial agreements for its lucrative, global client base of pharma and biotech companies. Practice head Roberto Valenti is well-equipped to assist clients with the full range of soft IP disputes and commercial issues surrounding medical devices. Marco de Morpurgo divides his time between Rome and Brussels, with his primary area of expertise being EU and Italian regulation of biotech, medical devices, and pharma products. Raffaella Quintana stands out due to her longstanding expertise in internal investigations and commercial fraud matters within the life sciences space, often representing pharma companies, while regulatory expert Nicola Landolfi is known for his vast knowledge of both EU and Italian law governing the licensing of products and clinical trials.